AliveCor QT Service vs Reveal LINQ Insertable Cardiac Monitor
AI Verdict
Choose AliveCor QT Service if…
Choose AliveCor QT Service if you need immediate and accurate QT/QTc interval measurements to inform medication prescribing decisions and assess cardiac safety in a clinical setting. This cloud-based SaMD is ideal for healthcare professionals requiring on-demand analysis of AliveCor 6-Lead ECGs, especially when managing patients on drugs known to prolong the QT interval.
View AliveCor QT Service →Choose Reveal LINQ Insertable Cardiac Monitor if…
Choose Reveal LINQ Insertable Cardiac Monitor if your patient requires continuous, long-term monitoring for infrequent arrhythmias such as atrial fibrillation or unexplained syncope, over an extended period. This implantable device, with its AccuRhythm AI, is best suited for diagnosing elusive cardiac events that may not be captured by shorter-term external monitoring solutions, offering up to 4.5 years of continuous data collection.
View Reveal LINQ Insertable Cardiac Monitor →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AliveCor QT Service | Reveal LINQ Insertable Cardiac Monitor |
|---|---|---|
| Pricing | Varies by product and service, with subscription options available. | Contact vendor |
| Deployment | Mobile app, cloud-based platform, EHR integration. | Implantable device with data transmitted to a cloud-based platform (CareLink™ network) via patient smartphone app or home communicator. |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AliveCor QT ServiceTool A, the AliveCor QT Service, offers a non-invasive approach for patients using an ambulatory ECG device, providing instant QT measurements. Its cloud-based nature and integration with existing portals suggest a streamlined workflow for healthcare professionals to access and interpret critical data efficiently.
Clinical Value
Reveal LINQ Insertable Cardiac MonitorTool B, the Reveal LINQ ICM, provides continuous, long-term monitoring for elusive cardiac conditions like atrial fibrillation and syncope over 4.5 years. Its AccuRhythm AI algorithms are specifically designed to reduce false alerts and enhance diagnostic yield, addressing a significant challenge in long-term arrhythmia detection.
Pricing & Value
TieBoth tools require direct contact with the vendor for pricing details, making it impossible to compare their cost-effectiveness or overall value proposition. Without transparent pricing, a definitive winner cannot be determined in this dimension.
Enterprise Readiness
AliveCor QT ServiceWhile both are FDA-cleared, HIPAA compliant, and offer BAAs, Tool A explicitly states the availability of an API for integration with EHR, SDK, CRM, EDC, and PSP platforms. This explicit mention of broad integration capabilities demonstrates a higher degree of stated enterprise readiness for seamless data flow into diverse healthcare IT ecosystems.
Innovation
Reveal LINQ Insertable Cardiac MonitorTool B's AccuRhythm AI algorithms represent a significant innovation by specifically targeting and reducing false alerts in long-term cardiac monitoring, a common challenge with implantable devices. Combined with its 4.5-year battery longevity and remote programming capabilities, it pushes the boundaries of implantable cardiac monitoring technology.
Support & Docs
TieThe provided structured facts do not contain any specific information regarding the availability of support channels, documentation, or training programs for either Tool A or Tool B. Therefore, it is not possible to differentiate between them on this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AliveCor QT Service | Reveal LINQ Insertable Cardiac Monitor |
|---|---|---|
| Name | AliveCor QT Service | Reveal LINQ Insertable Cardiac Monitor |
| Company | AliveCor | Medtronic |
| Description | A cloud-based Software as a Medical Device (SaMD) that provides instant, accurate QT and QTc interval measurements from AliveCor 6-Lead ECGs, enabling healthcare professionals to assess cardiac safety and inform medication prescribing decisions. | The Medtronic LINQ IIu2122 Insertable Cardiac Monitor (ICM) with AccuRhythmu2122 AI algorithms provides long-term, accurate heart monitoring by using deep learning AI to reduce false alerts and enhance diagnostic yield for conditions like atrial fibrillation and syncope. |
| Key Feature 1 | Cloud-based Software as a Medical Device (SaMD) | AccuRhythmu2122 AI algorithms for reduced false alerts (AF and Pause) |
| Key Feature 2 | Measures QT and QTc intervals (Bazett's and Fridericia's formulas) | 4.5-year battery longevity (nominal settings) |
| Key Feature 3 | Analyzes ECGs from AliveCor 6-Lead ambulatory ECG devices (e.g., KardiaMobile 6L) | Continuous, long-term subcutaneous ECG monitoring |
| Specialties | Cardiology, Emergency Medicine, Internal Medicine | Cardiology, Pediatrics |
Videos
Demos, reviews, and walkthroughs featuring AliveCor QT Service and Reveal LINQ Insertable Cardiac Monitor.
Frequently Asked Questions
More Comparisons
More matchups featuring AliveCor QT Service or Reveal LINQ Insertable Cardiac Monitor
Backers
Who funded each tool's parent company.